Methoden vergleichen

	Subtiles Substanzmissbrauch-Screening-Inventar (SASSI)	Brief Addiction Monitor (BAM)	Cannabis-Konsumstörungen-Identifikationstest
Fachgebiet	Suchtmedizin	Suchtmedizin	Suchtmedizin
Familie	Process / pipeline	Process / pipeline	Process / pipeline
Entstehungsjahr	1997	2013	2010
Urheber	Miller, Lazowski	Cacciola, Alterman, Drapkin, Valadez	Adamson, Kay-Lambkin, Baker, Lewin, Thornton, Kelly, Sellman
Typ	Self-report	Self-report	Self-report
Wegweisende Quelle	Miller, G. A. (1997). The Substance Abuse Subtle Screening Inventory-2 (SASSI-2) manual. Spencer, IN: Spencer Psychology Press.	Cacciola, J. S., Alterman, A. I., Drapkin, M. L., & Valadez, C. (2013). Development and initial validation of the Brief Addiction Monitor (BAM). Journal of Substance Abuse Treatment, 44(3), 256–263.	Adamson, S. J., Kay-Lambkin, F. J., Baker, A. L., Lewin, T. J., Thornton, L., Kelly, B. J., & Sellman, J. D. (2010). An improved brief screening instrument for cannabis use disorder. Drug and Alcohol Dependence, 110(1–2), 55–60.
Aliasnamen	SASSI	BAM	CUDIT-R, CUDIT
Verwandt	4	4	4
Zusammenfassung	The SASSI is a comprehensive self-report inventory designed to identify substance abuse and dependence through both direct and indirect assessment methods. Developed by Glenn Miller in 1997 and updated to the SASSI-3 format, it employs 'subtle' items that indirectly measure substance abuse risk without openly asking about drug or alcohol use, thereby reducing response bias and improving detection in individuals who may be motivated to minimize their substance use. The SASSI is widely used in clinical, occupational health, and criminal justice settings.	The BAM is a 17-item self-report instrument designed to provide rapid, multimodal assessment of substance use, craving, risk factors, protective factors, and psychosocial functioning in individuals receiving addiction treatment. Developed by Cacciola and colleagues in 2013, it serves as an efficient outcome monitoring tool for tracking treatment progress, identifying relapse warning signs, and guiding therapeutic adjustments. The BAM is useful in treatment settings where frequent assessment of multiple domains is needed to optimize care.	The CUDIT-R is a brief, 8-item self-report screening instrument developed to identify cannabis use disorder and hazardous cannabis use patterns. Introduced by Adamson and colleagues in 2010 as a revision of the original CUDIT, the CUDIT-R improves brevity and screening efficiency while maintaining strong psychometric properties. It is designed for use in primary care, addiction treatment, and public health settings to detect problematic cannabis use and inform treatment allocation decisions.